相关实验视频

Updated: Jan 13, 2026

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

莱沃多巴和亚体内核深脑刺激对帕金森病运动特征的差异化影响

Tiffanie A Lee¹, Deepa Ramesh¹, Mwiza Ushe²

¹University of North Carolina at Chapel Hill, Department of Neurology, 170 Manning Drive, Chapel Hill, NC 27599, USA.

Clinical parkinsonism & related disorders

|January 9, 2026

概括

莱沃多巴和亚体内核深度大脑刺激 (STN DBS) 对帕金森病的运动症状提供了明显的好处. 列沃多巴在轴心症状方面表现出色,而STN DBS在上肢震方面略好一些,指导个性化治疗选择.

科学领域:

神经学神经学
神经外科神经外科
运动障碍运动障碍

背景情况:

脑下核深度大脑刺激 (STN DBS) 是帕金森病 (PD) 运动波动的主要手术治疗方法.
莱沃多巴输送的进步提供了非侵入性的替代方案,促使对治疗疗效进行比较.
了解不同的治疗效果对于优化患者管理至关重要.

研究的目的:

系统地比较勒沃多巴和STN DBS对特定帕金森运动组件的影响.
为了确定哪些运动症状是每个模式更有效地治疗.
为PD治疗选择的临床决策提供信息.

主要方法:

对接受双边STN DBS的395名PD患者的回顾性分析.
在术前OFF-药物,术前ON-药物和术后ON-DBS/OFF-药物状态下评估UPDRS-III分数.
探索性因子分析以确定症状集群和威尔科克森等级总和测试/肯达尔的,以比较治疗反应和相关性.

主要成果:

利沃多巴和STN DBS都显著改善了所有运动特征.
利沃多巴对轴心症状和下肢/肌动力更有效.
在STN DBS中,STN DBS在上肢震方面显示出略有优异的疗效.
对于刚性,勃拉迪基尼西亚和轴心症状的治疗反应之间观察到弱但显著的相关性.

结论:

利沃多巴和STN DBS对于帕金森病的运动领域具有独特的治疗特征.
治疗反应之间的弱相关性表明,乐伏多巴反应可能无法可靠地预测DBS候选性.
建议根据患者的特定症状概况进行个性化治疗选择.

关键词:

深度大脑刺激是什么?进行了因素分析.利沃多帕 (Levodopa) 是一种可靠的药物.帕金森病是帕金森病的一种疾病.

更多相关视频

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.